X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47816) 47816
Newsletter (7661) 7661
Publication (5275) 5275
Newspaper Article (3293) 3293
Book Review (323) 323
Book Chapter (283) 283
Dissertation (135) 135
Conference Proceeding (88) 88
Government Document (79) 79
Magazine Article (41) 41
Trade Publication Article (29) 29
Book / eBook (16) 16
Web Resource (15) 15
Reference (7) 7
Data Set (6) 6
Transcript (6) 6
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30140) 30140
epidermal growth factor (28421) 28421
index medicus (24383) 24383
oncology (16700) 16700
cancer (15467) 15467
female (13524) 13524
animals (11882) 11882
research (11698) 11698
receptor, epidermal growth factor - metabolism (10992) 10992
male (10099) 10099
mutation (8966) 8966
receptor, epidermal growth factor - genetics (8537) 8537
middle aged (7825) 7825
epidermal growth factor receptors (7508) 7508
cell line, tumor (7075) 7075
egfr (6971) 6971
aged (6861) 6861
lung cancer (6832) 6832
epidermal growth factor receptor (6736) 6736
expression (6685) 6685
tumors (6613) 6613
receptor, epidermal growth factor - antagonists & inhibitors (6601) 6601
signal transduction (6495) 6495
mice (6434) 6434
care and treatment (6426) 6426
chemotherapy (6187) 6187
kinases (6088) 6088
genetic aspects (6086) 6086
growth-factor receptor (5926) 5926
proteins (5909) 5909
analysis (5861) 5861
cell biology (5858) 5858
adult (5824) 5824
phosphorylation (5306) 5306
metastasis (5233) 5233
lung cancer, non-small cell (5110) 5110
gefitinib (5091) 5091
biochemistry & molecular biology (4837) 4837
tyrosine (4804) 4804
epidermal-growth-factor (4771) 4771
prognosis (4580) 4580
apoptosis (4225) 4225
breast cancer (4219) 4219
gene expression (4127) 4127
lung neoplasms - genetics (4059) 4059
immunohistochemistry (3980) 3980
lung neoplasms - drug therapy (3900) 3900
cancer therapies (3811) 3811
oncology, experimental (3802) 3802
antineoplastic agents - therapeutic use (3761) 3761
health aspects (3757) 3757
activation (3703) 3703
reports (3634) 3634
medicine (3517) 3517
article (3478) 3478
patients (3417) 3417
aged, 80 and over (3278) 3278
research article (3245) 3245
carcinoma, non-small-cell lung - drug therapy (3210) 3210
lung neoplasms - pathology (3188) 3188
erlotinib (3056) 3056
multidisciplinary sciences (3013) 3013
survival (2982) 2982
therapy (2966) 2966
antineoplastic agents - pharmacology (2955) 2955
development and progression (2902) 2902
carcinoma, non-small-cell lung - genetics (2865) 2865
adenocarcinoma (2830) 2830
cell proliferation (2766) 2766
medical research (2764) 2764
cetuximab (2685) 2685
signal transduction - drug effects (2573) 2573
cells (2570) 2570
studies (2553) 2553
pathology (2507) 2507
science (2462) 2462
medical prognosis (2444) 2444
ligands (2424) 2424
colorectal cancer (2395) 2395
cell lung-cancer (2386) 2386
physiological aspects (2373) 2373
treatment outcome (2363) 2363
medicine & public health (2309) 2309
pharmacology & pharmacy (2279) 2279
cell proliferation - drug effects (2273) 2273
carcinoma (2267) 2267
breast-cancer (2256) 2256
protein kinase inhibitors - therapeutic use (2227) 2227
factor receptor (2209) 2209
universities and colleges (2202) 2202
carcinoma, non-small-cell lung - pathology (2170) 2170
quinazolines - pharmacology (2162) 2162
rodents (2162) 2162
egf receptor (2160) 2160
gene expression regulation, neoplastic (2114) 2114
epidermal growth factor - metabolism (2097) 2097
biochemistry (2082) 2082
protein kinase inhibitors - pharmacology (2077) 2077
growth factors (2063) 2063
epidermal growth factor - pharmacology (2022) 2022
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57710) 57710
Chinese (744) 744
French (198) 198
Japanese (181) 181
German (127) 127
Korean (95) 95
Spanish (64) 64
Russian (53) 53
Polish (27) 27
Hungarian (20) 20
Czech (17) 17
Portuguese (16) 16
Italian (10) 10
Turkish (9) 9
Dutch (6) 6
Bulgarian (4) 4
Swedish (3) 3
Croatian (2) 2
Norwegian (2) 2
Persian (2) 2
Arabic (1) 1
Danish (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Science, ISSN 1347-9032, 12/2016, Volume 107, Issue 12, pp. 1800 - 1805
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain... 
EGFR mutation | radiotherapy | prognosis | Brain metastasis | lung adenocarcinoma | CANCER PATIENTS | GEFITINIB | PHASE-II | RADIATION-THERAPY | TKI | ONCOLOGY | MUTATIONS | ERLOTINIB | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Brain Neoplasms - secondary | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Brain Neoplasms - mortality | Lung Neoplasms - genetics | ErbB Receptors - antagonists & inhibitors | Proportional Hazards Models | Treatment Outcome | Combined Modality Therapy | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Brain Neoplasms - therapy | Radiotherapy - methods | Aged | Mutation | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma | Tyrosine | Brain | Medical research | Care and treatment | Epidermal growth factor | Lung cancer | Brain tumors | Medicine, Experimental | Phenols | Metastasis | Radiotherapy | Medical imaging | Epidermal growth factor receptors | Brain cancer | Oncology | Nervous system | Radiation therapy | Cancer therapies | Survival | Patients | Disease control | Metastases | Studies | Survival analysis | Neurotoxicity | Clonal deletion | Medical prognosis | Response rates | Protein-tyrosine kinase | Original
Journal Article
Gene, ISSN 0378-1119, 2006, Volume 366, Issue 1, pp. 2 - 16
The epidermal growth factor receptor (EGFR) belongs to the ErbB family of receptor tyrosine kinases (RTK). These -membrane proteins are activated following... 
Signal transduction | ErbB | EGF | Growth factors | ERBB-FAMILY RECEPTORS | growth factors | signal transduction | EXTRACELLULAR DOMAIN | HUMAN BREAST-CANCER | FACTOR-ALPHA CDNA | CELL LUNG-CANCER | MAMMARY-GLAND DEVELOPMENT | GENETICS & HEREDITY | TYROSINE KINASE INHIBITOR | TGF-ALPHA | GENE COPY NUMBER | TRANSGENIC MICE | Carcinoma - drug therapy | Receptor, Epidermal Growth Factor - genetics | Epidermal Growth Factor - genetics | Humans | Epidermal Growth Factor - metabolism | Protein Structure, Tertiary - genetics | Signal Transduction - genetics | Cell Transformation, Neoplastic - metabolism | Enzyme Inhibitors - therapeutic use | Gene Amplification - drug effects | Receptor, Epidermal Growth Factor - metabolism | Animals | Signal Transduction - drug effects | Cell Transformation, Neoplastic - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Carcinoma - genetics | Gene Amplification - genetics | Carcinoma - metabolism | Cell Transformation, Neoplastic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Mutation | Dimerization | Gene Expression Regulation, Neoplastic - genetics | Tyrosine | Cell research | Glycosaminoglycans | Development and progression | Anticoagulants (Medicine) | Hormones | Transforming growth factors | Lung cancer, Non-small cell | Phosphatidylinositol | Somatotropin | Keratin | Prolactin | Gliomas | Analysis | Phospholipases | Iron oxides | Health aspects | Protein kinases | Metallothionein | Cancer | Protein binding
Journal Article
Science Translational Medicine, ISSN 1946-6234, 12/2013, Volume 5, Issue 216, pp. 216ra177 - 216ra177
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2014, Volume 289, Issue 30, pp. 20813 - 20823
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2009, Volume 15, Issue 10, pp. 3484 - 3494
Purpose: The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) gefitinib and erlotinib benefit some non–small cell lung cancer (NSCLC)... 
resistance | Non-small cell lung cancer | EGFR inhibitors | CELL LUNG-CANCER | GEFITINIB | THERAPY | ONCOLOGY | HUMAN PANCREATIC-CARCINOMA | ACQUIRED-RESISTANCE | TYROSINE KINASE INHIBITOR | PHASE-II | MONOCLONAL-ANTIBODY | MUTATIONS | ANTITUMOR-ACTIVITY | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | NIH 3T3 Cells | Receptor, Epidermal Growth Factor - genetics | Humans | Lung Neoplasms - metabolism | Drug Resistance, Neoplasm | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Bevacizumab | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Receptors, Vascular Endothelial Growth Factor - metabolism | Transfection | Piperidines - pharmacology | Time Factors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Quinazolines - administration & dosage | Receptors, Vascular Endothelial Growth Factor - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Piperidines - administration & dosage | Antibodies, Monoclonal - pharmacology | Carcinoma, Non-Small-Cell Lung - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Quinazolines - pharmacology
Journal Article
Cancer Research, ISSN 0008-5472, 08/2004, Volume 64, Issue 15, pp. 5355 - 5362
Molecular inhibition of epidermal growth factor receptor (EGFR/HER1) signaling is under active investigation as a promising cancer treatment strategy. We... 
PATHWAYS | APOPTOSIS | HEAD | THERAPY | CANCER CELLS | ONCOLOGY | RESISTANCE | TUMOR-CELLS | PROLIFERATION | TARCEVA | BREAST | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Prostatic Neoplasms - metabolism | Apoptosis - drug effects | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Immunoblotting | Male | Transplantation, Heterologous | Head and Neck Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Flow Cytometry | Female | Quinazolines - administration & dosage | Phosphorylation - drug effects | Tumor Cells, Cultured | Cetuximab | Prostatic Neoplasms - drug therapy | Protein-Serine-Threonine Kinases - metabolism | Proto-Oncogene Proteins - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Enzyme Inhibitors - pharmacology | Head and Neck Neoplasms - drug therapy | Cell Division - drug effects | Proto-Oncogene Proteins c-akt | Animals | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Proliferating Cell Nuclear Antigen - metabolism | Mitogen-Activated Protein Kinases - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Expert Opinion on Drug Delivery, ISSN 1742-5247, 04/2019, Volume 16, Issue 4, pp. 441 - 451
Introduction: Malignant mesothelioma (MM) is an aggressive malignancy arising from the mesothelial cells lining the pleura and other serosal membranes. It is... 
targeted therapies | malignant mesothelioma | EGFR overexpression | Epidermal growth factor receptor (EGFR) | TYROSINE KINASE DOMAIN | PHASE-III | MALIGNANT PLEURAL MESOTHELIOMA | ANTIBODY | OPEN-LABEL | CELL LUNG-CANCER | PROTEIN EXPRESSION | EGFR EXPRESSION | PHARMACOLOGY & PHARMACY | GENE COPY NUMBER | ACTIVATING MUTATIONS
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2015, Volume 10, Issue 1, pp. 156 - 163
Journal Article